Nature Reviews Drug Discovery 5, 453–454 (2006)
On page 453, information summarizing the efficacy of ranolazine in the ERICA trial was reported incorrectly. The correct information is:
Statistically significant decreases in angina attack frequency and nitroglycerin use were observed in the ranolazine group compared with the placebo group (mean number of attacks/week = 3.3 and mean number of doses of nitroglycerin/week = 2.7 compared with 4.3 attacks/week and 3.6 doses of nitroglycerin/week, respectively)6.
Additional information
The online version of the original article can be found at 10.1038/nrd2069
Rights and permissions
About this article
Cite this article
Abrams, J., Jones, C. & Kirkpatrick, P. Erratum: Ranolazine. Nat Rev Drug Discov 5, 614 (2006). https://doi.org/10.1038/nrd2108
Issue Date:
DOI: https://doi.org/10.1038/nrd2108
